» Articles » PMID: 25449247

Historic and Current Hepatitis B Viral DNA and Quantitative HBsAg Level Are Not Associated with Cirrhosis in Non-Asian Women with Chronic Hepatitis B

Overview
Publisher Elsevier
Date 2014 Dec 3
PMID 25449247
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Some studies done in Asian patients have shown that serum levels of hepatitis B virus (HBV) DNA predict the development of cirrhosis. However, it is unclear whether this also applies for non-Asian patients. This study investigated historic and current HBV DNA and quantitative hepatitis B surface antigen (HBsAg) levels as predictors of cirrhosis in non-Asian women with chronic HBV.

Methods: A retrospective cohort study of non-Asian women with chronic HBV was performed. Among other variables, HBV DNA and quantitative HBsAg levels were measured in stored historic serum samples obtained during pregnancy (period 1990-2004) and current serum samples (period 2011-2012) to determine any association with liver cirrhosis by liver stiffness measurement (LSM).

Results: One hundred and nineteen asymptomatic, treatment-naïve non-Asian women were included; the median number of years between the historic sample and the current sample was 17 (interquartile range (IQR) 13-20). The median historic log HBV DNA and quantitative log HBsAg levels were 2.5 (IQR 1.9-3.4) IU/ml and 4.2 (IQR 3.6-4.5) IU/ml, respectively. LSM diagnosed 14 patients (12%) with F3-F4 fibrosis, i.e. stiffness >8.1kPa. No association of cirrhosis was found with historic HBV DNA (relative risk (RR) 0.34, 95% confidence interval (CI) 0.05-2.44) or with the quantitative HBsAg level (HBsAg level >1000 IU/ml, RR 0.35, 95% CI 0.11-1.11). Multivariable analysis identified alcohol consumption (odds ratio (OR) 6.4, 95% CI 1.3-30.1), aspartate aminotransferase >0.5 times the upper limit of normal (OR 15.4, 95% CI 1.9-122.6), and prothrombin time (OR 12.0, 95% CI 1.2-120.4), but not HBV DNA or quantitative HBsAg level, to be independent predictors of the presence of cirrhosis.

Conclusions: Neither historic nor current HBV DNA or the quantitative HBsAg level is associated with the development of HBV-related cirrhosis in non-Asian women.

Citing Articles

Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.

Tan M, Bhadoria A, Cui F, Tan A, Holten J, Easterbrook P Lancet Gastroenterol Hepatol. 2020; 6(2):106-119.

PMID: 33197397 PMC: 7801814. DOI: 10.1016/S2468-1253(20)30307-1.


Association between host TNF-α, TGF-β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV-associated chronic liver disease in Indonesian patients.

Kencono Wungu C, Amin M, Ruslan S, Purwono P, Kholili U, Maimunah U Biomed Rep. 2019; 11(4):145-153.

PMID: 31565220 PMC: 6759598. DOI: 10.3892/br.2019.1239.


The relationship between serum hepatitis B virus DNA level and liver histology in patients with chronic HBV infection.

Liu C, Wang L, Xie H, Zhang L, Wang B, Luo C PLoS One. 2018; 13(11):e0206060.

PMID: 30403735 PMC: 6221304. DOI: 10.1371/journal.pone.0206060.


Low serum hyaluronic acid levels associated with spontaneous HBsAg clearance.

Harkisoen S, Arends J, van den Hoek A, van Erpecum K, Boland G, Hoepelman A Eur J Clin Microbiol Infect Dis. 2015; 34(11):2183-9.

PMID: 26292936 PMC: 4607722. DOI: 10.1007/s10096-015-2467-x.